Aurinia Pharmaceuticals Inc. | Business Contracts

Form of Restricted Stock Unit Award under the Equity Incentive Plan (Filed With SEC on February 28, 2023)

Form of Inducement Restricted Stock Unit Award (Filed With SEC on February 28, 2023)

Separation Agreement between Aurinia Pharmaceuticals Inc. and Rob Huizinga dated October 20, 2022 (Filed With SEC on November 3, 2022)

Separation Agreement between Aurinia Pharmaceuticals Inc. and Neil Solomons dated October 20, 2022 (Filed With SEC on November 3, 2022)

Separation Agreement between Aurinia Pharma U.S. Inc. and Max Colao dated (Filed With SEC on November 3, 2022)

Supply Agreement by and between Aurinia Pharmaceuticals Inc. and Otsuka Pharmaceutical Co. Ltd. dated August 1, 2022 (Filed With SEC on August 4, 2022)

Employment Agreement between Aurinia Pharma U.S. Inc., and Scott Habig dated June 27, 2022 (Filed With SEC on August 4, 2022)

Employment Agreement between Aurinia Pharma U.S. Inc., and Volker Knappertz, M.D., dated July 11, 2022 (Filed With SEC on August 4, 2022)

Employment Agreement between the Registrant and Michael Martin dated October 1, 2017 (Filed With SEC on February 24, 2021)

Form of Inducement Grant Option Commitment (Filed With SEC on February 24, 2021)

Separation Agreement between Aurinia Pharma U.S., Inc. and Erik Eglite dated October 26, 2020 (Filed With SEC on February 24, 2021)

Employment Agreement between the Registrant and Neil Solomons dated October 1, 2017 (Filed With SEC on February 24, 2021)

Employment Agreement between the Registrant and Stephen Robertson dated September 29, 2020 (Filed With SEC on February 24, 2021)

Employment Agreement between Aurinia Pharma U.S. Inc. and Joe Miller dated April 8, 2020 (Filed With SEC on February 24, 2021)

Form of Common Shares Certificate of the Company (Filed With SEC on February 24, 2021)

Employment Agreement between the Registrant and Robert Huizinga dated October 1, 2017 (Filed With SEC on February 24, 2021)

Employment Agreement between Aurinia Pharma U.S. Inc. and Max Donley dated July 15, 2019 (Filed With SEC on February 24, 2021)

Employment Agreement between Aurinia Pharma U.S. Inc. and Max Colao dated February 10, 2020 (Filed With SEC on February 24, 2021)

Employment Agreement between Aurinia Pharma U.S., Inc. and Peter Greenleaf dated April 11, 2019 (Filed With SEC on February 24, 2021)

Settlement Agreement among ILJIN Life Science Co. Ltd., Isotechnika Pharma Inc., and Aurinia Pharmaceuticals Inc., dated April 3, 2013 (Filed With SEC on February 24, 2021)

Softgel Commercial Supply Agreement between the Registrant and Catalent Pharma Solutions, LLC dated August 28, 2020 (Filed With SEC on February 24, 2021)

Lease agreement for space at Suite No. 1203 and No. 1201 Building No. 100, 4464 Markham Street Victoria, BC between University of Victoria Properties Investments, Inc. and the... (Filed With SEC on February 24, 2021)

Lease agreement for space at 2615-2629 Douglas Street, Victoria, BC between TC Evolution Limited Partnership and the Registrant dated August 12, 2020 (Filed With SEC on February 24, 2021)

Lease agreement for space at 77 Upper Rock Circle, Rockville, MD (Filed With SEC on February 24, 2021)

Manufacturing Services Agreement between the Registrant and Lonza Ltd. dated November 16, 2020 (Filed With SEC on February 24, 2021)

Form of Indemnity Agreement between the Registrant and each of its Directors and Executive Officers (Filed With SEC on February 24, 2021)

Description of the Registrant's Common Shares (Filed With SEC on February 24, 2021)

Aurinia Pharmaceuticals Inc. (27)